By Globalfinserve Business Desk
March 2025
Axon Enterprise Inc. (NASDAQ: AXON), a leading defense technology company known for its Taser products and body cameras, has seen its stock price decline by 2.3% over the past month, underperforming the broader S&P 500 index. This downward trend comes despite the company’s strong financial performance in its most recent earnings report.
With analyst estimates trending lower and a weaker outlook for near-term returns, Axon’s stock faces a challenging period ahead. This article explores the company’s latest financial results, stock performance, industry trends, and future outlook.
✅ Axon’s Latest Earnings Report: Solid Growth, But Mixed Momentum
Axon’s Q4 2024 earnings report showed revenue growth but also revealed declining stock momentum, resulting in downward revisions from analysts.
1. Revenue and Profitability Performance
- Revenue: Axon reported $1.14 billion in revenue for Q4 2024, marking a 16% year-over-year increase from $983 million in Q4 2023.
- Earnings per Share (EPS): The company posted an EPS of $0.87, exceeding Wall Street estimates of $0.82.
- Gross Margin: Axon’s gross margin expanded to 63.2%, driven by increased Taser device sales and recurring software revenue from its Axon Cloud platform.
2. Key Growth Drivers
Axon continues to benefit from strong demand for its:
- Taser 7 products: Sales of the latest-generation Taser devices surged 23% year-over-year.
- Body cameras and cloud solutions: Law enforcement agencies increasingly adopt Axon’s digital evidence management software, boosting recurring revenue.
- International expansion: Axon reported double-digit sales growth in key international markets, particularly in Europe and Asia-Pacific.
✅ Stock Performance: Declining Momentum Despite Growth
Despite solid earnings, Axon’s stock price has declined by 2.3% over the past month, signaling weak investor sentiment.
1. VGM Score and Rank
According to Zacks Investment Research, Axon holds:
- VGM Score: D, indicating weak overall performance across Value, Growth, and Momentum factors.
- Growth Score: A, reflecting the company’s strong revenue expansion and increasing profitability.
- Momentum Score: F, signaling weak recent stock price trends.
- Zacks Rank: #3 (Hold), suggesting average near-term returns.
2. Downward Estimate Revisions
Since its last earnings release, analysts have lowered their EPS estimates for Axon’s next quarter by 107.22%.
- The consensus EPS estimate for the upcoming quarter is $0.79, down from $0.85 previously.
- This downward revision reflects concerns about slowing sales growth and rising operating expenses.
✅ Industry Comparison: Curtiss-Wright Outperforms Axon
Axon’s recent stock performance lags behind its industry peer, Curtiss-Wright Corporation (NYSE: CW), a defense and aerospace equipment manufacturer.
1. Curtiss-Wright’s Q4 2024 Earnings
- Revenue: Curtiss-Wright reported $824.3 million in Q4 2024 revenue, a 4.9% increase year-over-year.
- EPS: The company posted EPS of $3.27, up from $3.16 a year ago.
- Stock Performance: Curtiss-Wright’s stock gained 3.4% over the past month, outperforming Axon.
2. Zacks Rank and VGM Score
- Zacks Rank: #3 (Hold), the same as Axon.
- VGM Score: C, slightly better than Axon’s D rating.
- Curtiss-Wright’s better stock momentum reflects investor preference for traditional defense companies over tech-driven firms like Axon.
✅ Factors Impacting Axon’s Outlook
Axon’s near-term stock performance faces multiple headwinds despite its strong revenue growth.
1. Rising Operating Expenses
- Axon’s operating expenses surged by 18% year-over-year due to higher R&D spending and marketing costs.
- The company’s focus on expanding its cloud platform and developing new products could weigh on its profitability margins.
2. Competitive Pressure
- Increased competition from body camera rivals like Motorola Solutions (MSI) and Digital Ally (DGLY) is intensifying.
- To maintain its market leadership, Axon may have to cut prices or increase marketing spend, pressuring its bottom line.
3. Macroeconomic Risks
- With rising interest rates and broader market volatility, tech-driven defense stocks like Axon face increased risk of stock underperformance.
- Investors are favoring traditional industrial defense companies over technology-heavy players.
✅ Analyst Recommendations
Despite its recent stock decline, analysts remain moderately optimistic about Axon’s long-term growth potential.
1. Ratings and Price Targets
- JP Morgan: Maintains an Overweight rating with a price target of $310, citing strong cloud revenue growth.
- Goldman Sachs: Reiterates a Neutral rating, forecasting short-term volatility due to rising expenses.
- Bank of America: Downgrades to Hold, with a revised price target of $280, highlighting weaker near-term earnings momentum.
2. Consensus Outlook
- Current analyst consensus: Hold
- Average price target: $295, representing a 5.2% upside from current levels.
✅ Key Takeaways for Investors
- Revenue growth: Axon delivered strong year-over-year revenue growth of 16%, driven by Taser sales and cloud subscriptions.
- Stock underperformance: Despite solid financials, AXON shares declined 2.3%, underperforming the broader market.
- Estimate revisions: Analysts have lowered their EPS estimates, citing concerns over rising expenses and slowing growth.
- Competitive landscape: Axon faces increasing competition in the defense technology market, which could impact its future profitability.
✅ Investment Outlook: Cautiously Optimistic
Axon remains a solid long-term investment due to its recurring revenue model and growing international footprint. However, its near-term stock performance may remain volatile due to rising operating expenses and industry competition.
Investors with a long-term horizon may view the recent stock decline as a buying opportunity, while short-term traders may prefer to wait for stability before increasing exposure.
✅ Conclusion
Axon Enterprise’s recent stock performance reflects short-term challenges, including rising costs and downward estimate revisions, despite its strong revenue growth.
While the company’s long-term fundamentals remain strong, investors should expect near-term volatility. Analysts recommend a Hold rating, with moderate upside potential over the next few months.
For latest Business and Finance News subscribe to Globalfinserve, Click here.